Amrutanjan Healt (AMRUTANJAN)
STALWARTFairStock Score: 29/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 1/2 · Dividend: 0/1
Key Financials
| Current Price | ₹578 |
| Market Cap | ₹1,725.24 Cr |
| P/E Ratio | 29.84 |
| ROCE | 22.45% |
| ROE | 19.11% |
| Dividend Yield | 0.77% |
| Profit Growth | 5.82% |
| Debt/Equity | 0.01 |
| Sales Growth | 14.9% |
| Promoter Holding | 46.52% |
| 52-Week Range | ₹486 — ₹790.95 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹105.29 |
Amrutanjan Healt trades with a P/E ratio of 29.84, ROCE of 22.45%, ROE of 19.11%, profit growth of 5.82%, debt-to-equity of 0.01. The FairStock Score of 29/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer